| Tested feature |
The level of family’s knowledge about the disease: |
| Total N=1366 |
Moderate
(20,0-13,5 points)
N=48
3,5% |
Minimal
(13,0-6,5 points)
N=599
43,9% |
None
(6-0 points) N=719
52,6% |
| BMI: |
Chi^2 Pearsona: 28,6596, df=6, p<0,0005 |
| Normal weight BMI: (M<24,9 ;
W<23,9) |
11 |
5,9% |
100 |
53,5% |
76 |
40,6% |
| Overweight, BMI: (M=25-29,9 ;
W=24-29,9) |
21 |
4,3% |
222 |
45,3% |
247 |
50,4% |
| Obesity, BMI: (30-40) |
14 |
2,4% |
245 |
41,8% |
327 |
55,8% |
| Giant obesity, BMI: (>40) |
1 |
1,2% |
24 |
28,2% |
60 |
70,6% |
| WHR: |
Chi^2 Pearsona: 18,6279, df=4, p<0,005 |
| Type AO (M >=1 ; W => 0,85) |
15 |
2,3% |
272 |
41,1% |
375 |
56,6% |
| Type GO (M<1 ; W<0,85) |
18 |
4,0% |
194 |
43,4% |
235 |
52,6% |
| Does not apply WHR |
11 |
5,9% |
100 |
53,5% |
76 |
40,6% |
| Waist circumference and a risk of metabolic complications (waist circumference in men > 94 cm and
in women > 80 cm, with BMI>25): |
Chi^2 Pearsona: 23,3133, df=2, p<0,00005 |
| Increased |
25 |
2,4% |
426 |
41,8% |
569 |
55,8% |
| Normal |
19 |
6,4% |
151 |
51,2% |
125 |
42,4% |
| Blood pressure [mm/Hg]: |
Chi^2 Pearsona: 28,4760, df=6, p<0,005 |
| (<120-130 and <80-85) |
15 |
7,9% |
78 |
41,0% |
97 |
51,1% |
| (130-139 and 85-89) |
8 |
5,2% |
71 |
46,4% |
74 |
48,4% |
| (140-159 and 90-99) |
18 |
3,4% |
257 |
47,9% |
261 |
48,7% |
| (>160-179 / 100-109 and >=180 / >100) |
7 |
1,5% |
187 |
39,2% |
283 |
59,3% |
| Triglycerides [mg/dl]: |
Chi^2 Pearsona: 13,1950, df=4, p<0,05 |
| < 150 mg/dl |
16 |
7,6% |
88 |
41,7% |
107 |
50,7% |
| 150-200mg/dl |
1 |
0,5% |
82 |
44,6% |
101 |
54,9% |
| > 200 mg/dl |
4 |
3,0% |
58 |
43,6% |
71 |
53,4% |
| Physical fitness: |
Chi^2 Pearsona: 49,0203, df=6, p<0,00001 |
| Physically fit (7 points) |
10 |
8,2% |
70 |
57,9% |
41 |
33,9% |
| Few limitations of physical ability
(8-14 points) |
24 |
3,8% |
298 |
47,2% |
310 |
49,0% |
| Many limitations of physical ability
(in at least one factor) (15-21 points) |
13 |
2,4% |
189 |
35,3% |
334 |
62,3% |
| Lack of physical ability in at least one factor (22-28 points) |
1 |
1,3% |
42 |
54,5% |
34 |
44,2% |
| Independence: |
Chi^2 Pearsona: 50,7848, df=6, p<0,00001 |
| Fully independent |
15 |
8,2% |
104 |
56,8% |
64 |
35,0% |
| Insignificant limitations of independence |
21 |
4,2% |
232 |
46,7% |
244 |
49,1% |
| Marked limitations of independence
(partially unable to perform a minimum of 1 activity) |
12 |
1,9% |
237 |
37,9% |
376 |
60,2% |
| No independence (totally unable to
perform a minimum of 10 activity) |
0 |
0,0% |
26 |
42,6% |
35 |
57,4% |
| Somatic ailments: |
Chi^2 Pearsona: 17,0339, df=4, p<0,005 |
| None |
34 |
4,0% |
407 |
47,7% |
413 |
48,3% |
| Single (1-2) |
12 |
2,9% |
155 |
37,2% |
249 |
59,9% |
| Many (3 and more) |
2 |
2,1% |
37 |
38,5% |
57 |
59,4% |
| Disturbances and symptoms in the psycho-emotional life |
Chi^2 Pearsona: 22,7602, df=6, p<0,005 |
| No ailments |
29 |
4,5% |
310 |
48,1% |
306 |
47,4% |
| 1-2 ailments |
9 |
2,0% |
170 |
37,2% |
278 |
60,8% |
| 3-4 ailments |
4 |
2,9% |
63 |
46,0% |
70 |
51,1% |
| 5 and more ailments |
5 |
5,7% |
37 |
42,0% |
46 |
52,3% |
| Concomitant diseases: |
Chi^2 Pearsona: 22,3669, df=6, p<0,005 |
| No diagnosis of concomitant diseases |
10 |
6,7% |
82 |
54,6% |
58 |
38,7% |
| 1-2 concomitant diseases |
25 |
4,2% |
250 |
41,7% |
325 |
54,1% |
| 3-4 concomitant diseases |
7 |
1,7% |
172 |
41,4% |
236 |
56,9% |
| 5 and more concomitant diseases |
6 |
3,0% |
95 |
47,2% |
100 |
49,8% |
|
